Durham-based Atsena Therapeutics, a clinical-stage gene therapy company focused on using genetic medicine to reverse or prevent blindness, has dosed the first patient in the Phase 3 pivotal cohort of ...

Gene therapy legend R. Jude Samulski, Ph.D., co-founder and chief scientific officer of Asklepios BioPharmaceutical (AskBio) since the company was established in 2001, is leaving the CSO job but ...

Raleigh-based Marius Pharmaceuticals, led by several former GlaxoSmithKline scientists and executives, is making progress on its first potential drug. Marius has submitted a New Drug Application (NDA) ...

Caidya, a global clinical research organization based in Raleigh, has announced it is combining with UK-based CRO ...

Join us in Research Triangle Park (RTP) for lunch, expert presentations, and networking focused on accelerating complex drug development. Stick around for the RTP Roadshow—a half-day symposium ...

Durham-based 410 Medical, a medical device company developing new technologies for emergency and critical care, has raised ...

Clean Cells, a France-based provider of quality testing services for biopharmaceutical products, will acquire Stem Genomics, ...

I had the opportunity to participate in a panel discussion reflecting on my experiences working with both EBRC and the ...

More than 100 Research Triangle Park officials and other supporters gathered on Thursday for a celebration at HUB RTP to mark ...

Kymanox has opened a new Formulation Lab to provide formulation development and analytical testing services for pharmaceutical and biotechnology companies moving programs from early research into ...

Building on initial successes, the program got a significant funding boost in 2022 with the Accelerate NC - Life Sciences Manufacturing initiative. Accelerate NC, led by NCBiotech, was funded by a $25 ...

Pathalys Pharma, a Research Triangle Park-based biopharmaceutical company developing therapies for end-stage kidney disease, has secured $150 million in new financing to support phase 3 clinical ...